|
Title
|
|
|
|
Added value of long-term cytokine release assays to detect mycobacterium tuberculosis infection in HIV-infected subjects in Uganda
| |
|
Author
|
|
|
|
| |
|
Institution/Organisation
|
|
|
|
TB-IRIS Study Grp
| |
|
Abstract
|
|
|
|
| Objectives: To investigate whether mycobacterial antigen-induced cytokine secretions are helpful in detecting Mycobacterium tuberculosis (Mtb) infection in a cohort of HIV-infected patients living in a country with a high burden of Mtb and HIV infections, and to determine their predictive value for the development of tuberculosis (TB)-associated immune reconstitution inflammatory syndrome. Design: A total of 352 HIV-infected patients (186 with active TB) were prospectively enrolled when initiating antiretroviral therapy (ART). Sequential blood samples were collected during the first 6 months of ART. Eighty-three HIV-uninfected subjects (39 with active TB) were enrolled as controls. Methods: The concentrations of 13 cytokines were measured in supernatants from blood mononuclear cells in vitro stimulated with purified protein derivative (PPD), heparin-binding hemagglutinin (HBHA) or early secreted antigen-6 (ESAT-6) and culture filtrate protein-10 (CFP-10), and results were compared with those of tuberculin skin tests (TST). Results: The best detection of Mtb infection was achieved by ESAT-6/CFP-10-induced interferon-gamma concentrations, but results were often negative for patients with CD4(+) T-cell counts <50 per cubic millimeters. Patients with active TB were identified by high ESAT-6/CFP-10-induced interleukin-6. Conversions of interferon-gamma-release assays (IGRA) and TST occurred under ART, and combined TB and antiretroviral treatments of coinfected patients resulted in a decrease of ESAT-6/CFP-10-induced and an increase of HBHA-induced interferon-gamma responses. No Mtb antigen-induced cytokines allowed us to predict TB-immune reconstitution inflammatory syndrome or ART-associated TB. Conclusions: In Uganda, ESAT-6/CFP-10-IGRA is better in detecting Mtb infection than TST and, when combined with an HBHA-IGRA, could help to evaluate anti-TB treatment success. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
JAIDS. - Philadelphia, Pa
| |
|
Publication
|
|
|
|
Philadelphia, Pa
:
2016
| |
|
ISSN
|
|
|
|
1525-4135
| |
|
DOI
|
|
|
|
10.1097/QAI.0000000000000980
| |
|
Volume/pages
|
|
|
|
72
:3
(2016)
, p. 344-352
| |
|
ISI
|
|
|
|
000378059800023
| |
|
Pubmed ID
|
|
|
|
27306506
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (publisher's version - intranet only)
|
|
|
|
| |
|